Skip to main content

Corporate insider profile

John R Stuelpnagel Insider Trades

Latest reported as Director of 10x Genomics, Inc. (TXG).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,390,128.00
Latest transaction
Sep 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 3, 202610x Genomics, Inc. (TXG)DirectorSale20,000$61.75$1,235,072
Aug 11, 202610x Genomics, Inc. (TXG)DirectorSale20,000$57.75$1,155,056